Delcath Systems, Inc. (NasdaqCM: DCTH)
Health Care · Health Care Equipment & Supplies · US
$16.92
-1.28% today · +54.1% 1Y
Delcath Systems, Inc. (NasdaqCM: DCTH) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $594.74M and employs 156 people.
Over the last twelve months the share price has gained 54.1%, trading between 8.12 and 17.42.
Tweenvest scores Delcath Systems, Inc. across four factors: quality 45/100, value 52/100. Its strongest factor is value.
DCTH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $594.74M
- Revenue (TTM)
- $95.42M
- P/E
- —
- EPS
- 0.01
- Dividend yield
- —
- Beta (5Y)
- 0.52
- 52-week high
- $17.42
- 52-week low
- $8.12
- Avg volume (3M)
- —
- Shares outstanding
- 34.70M
- Employees
- 156
- Next earnings
- —
About Delcath Systems, Inc.
Delcath Systems, Inc. is an interventional oncology firm operating in the United States and Europe, dedicated to developing treatments for both primary and secondary liver cancers. Its leading investigational product is the HEPZATO KIT, a unique hepatic delivery system for melphalan that targets high-dose chemotherapy specifically to the liver. This innovative approach aims to substantially reduce systemic drug exposure and mitigate associated side effects. HEPZATO's clinical evaluation is advancing through the FOCUS trial, which is designed to assess the objective response rate in individuals with metastatic uveal melanoma whose disease is primarily concentrated in the liver. Furthermore, the company offers a separate version of HEPZATO as a medical device in Europe, marketed under the CHEMOSAT Hepatic Delivery System brand (or simply CHEMOSAT). This system empowers European medical centers to manage a diverse array of liver cancer conditions. Delcath Systems, Inc. was established in 1988, with its corporate headquarters situated in New York, New York.
- ISIN
- US24661P8077
- Founded
- 1988
- Listed since
- May 3, 2018
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $116.13 | 0.00% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $372.04 | +0.05% |
| Stryker CorporationNYSE: SYK | $126.81B | $332.44 | +0.56% |
| Medtronic plcNYSE: MDT | $116.66B | $91.10 | -0.04% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €160.65 | +0.94% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $46.91 | -5.92% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.87 | +0.41% |
Figures last refreshed Aug 18, 2026.